Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies

Authors: Libuse Tauchmanovà1; Carmine Selleri2; Gennaro De Rosa2; Mariarosaria Esposito2; Francesco Orio Jr1; Stefano Palomba3; Giuseppe Bifulco3; Carmine Nappi3; Gaetano Lombardi1; Bruno Rotoli2; Annamaria Colao1

Source: Human Reproduction, Volume 18, Number 7, July 2003 , pp. 1410-1416(7)

Publisher: Oxford University Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

BACKGROUND: Ovarian failure is a frequent complication occurring after haematopoietic stem cell transplantion (SCT), which is generally ascribed to radiation treatment and antiblastic alkylating agents. METHODS: Ovarian morphology and function were studied in reproductive age women 12–24 months after allogeneic SCT (n = 23) received from an HLA identical sibling, or autologous SCT (n = 22). Thirteen allo-transplanted women were suffering from chronic graft-versus-host disease (cGVHD). RESULTS: Menstrual cycles recovered in two and four women in the allo- and auto-SCT groups respectively, being associated with younger age and longer period elapsed from transplant. There was no difference in previous use of alkylating agents between allo- and auto-transplantation, while corticosteroid treatment was longer and more recent in the allo-SCT group. Significantly higher gonadotrophin levels and lower estradiol were seen in the combined group of patients than in controls. In allo-transplanted women, androgens were also significantly lower than in controls. Ovarian and uterine volumes were lower in patients than in controls, and in the allo- than in the auto-transplanted women. Within the allo-SCT group, endocrine function and ovarian and uterine volumes were significantly lower in the patients suffering from cGVHD. CONCLUSIONS: Ovarian failure in SCT recipients is likely to be caused principally by myelo-ablative treatments, but the condition of gonadal and androgen insufficiency can be worsened by an altered immunomodulation in allogeneic setting.

Keywords: busulphan/cyclophosphamide/graft-versus-host disea

Document Type: Research article

DOI: 10.1093/humrep/deg295

Affiliations: 1: Department of Molecular and Clinical Endocrinology and Oncology, 2: Division of Haematology, 3: Department of Gynaecology and Obstetrics, ‘Federico II’ University of Naples, via S.Pansini 5, 80131 Naples and

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.19 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A